Exploring gene knockout strategies to identify potential drug targets using genome-scale metabolic models
Abstract Research on new cancer drugs is performed either through gene knockout studies or phenotypic screening of drugs in cancer cell-lines. Both of these approaches are costly and time-consuming. Computational framework, e.g., genome-scale metabolic models (GSMMs), could be a good alternative to...
Guardado en:
Autores principales: | , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5cc3d92f081c43a59c89d39d060694cf |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:5cc3d92f081c43a59c89d39d060694cf |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:5cc3d92f081c43a59c89d39d060694cf2021-12-02T15:13:10ZExploring gene knockout strategies to identify potential drug targets using genome-scale metabolic models10.1038/s41598-020-80561-12045-2322https://doaj.org/article/5cc3d92f081c43a59c89d39d060694cf2021-01-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-80561-1https://doaj.org/toc/2045-2322Abstract Research on new cancer drugs is performed either through gene knockout studies or phenotypic screening of drugs in cancer cell-lines. Both of these approaches are costly and time-consuming. Computational framework, e.g., genome-scale metabolic models (GSMMs), could be a good alternative to find potential drug targets. The present study aims to investigate the applicability of gene knockout strategies to be used as the finding of drug targets using GSMMs. We performed single-gene knockout studies on existing GSMMs of the NCI-60 cell-lines obtained from 9 tissue types. The metabolic genes responsible for the growth of cancerous cells were identified and then ranked based on their cellular growth reduction. The possible growth reduction mechanisms, which matches with the gene knockout results, were described. Gene ranking was used to identify potential drug targets, which reduce the growth rate of cancer cells but not of the normal cells. The gene ranking results were also compared with existing shRNA screening data. The rank-correlation results for most of the cell-lines were not satisfactory for a single-gene knockout, but it played a significant role in deciding the activity of drug against cell proliferation, whereas multiple gene knockout analysis gave better correlation results. We validated our theoretical results experimentally and showed that the drugs mitotane and myxothiazol can inhibit the growth of at least four cell-lines of NCI-60 database.Abhijit PaulRajat AnandSonali Porey KarmakarSurender RawatNandadulal BairagiSamrat ChatterjeeNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-13 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Abhijit Paul Rajat Anand Sonali Porey Karmakar Surender Rawat Nandadulal Bairagi Samrat Chatterjee Exploring gene knockout strategies to identify potential drug targets using genome-scale metabolic models |
description |
Abstract Research on new cancer drugs is performed either through gene knockout studies or phenotypic screening of drugs in cancer cell-lines. Both of these approaches are costly and time-consuming. Computational framework, e.g., genome-scale metabolic models (GSMMs), could be a good alternative to find potential drug targets. The present study aims to investigate the applicability of gene knockout strategies to be used as the finding of drug targets using GSMMs. We performed single-gene knockout studies on existing GSMMs of the NCI-60 cell-lines obtained from 9 tissue types. The metabolic genes responsible for the growth of cancerous cells were identified and then ranked based on their cellular growth reduction. The possible growth reduction mechanisms, which matches with the gene knockout results, were described. Gene ranking was used to identify potential drug targets, which reduce the growth rate of cancer cells but not of the normal cells. The gene ranking results were also compared with existing shRNA screening data. The rank-correlation results for most of the cell-lines were not satisfactory for a single-gene knockout, but it played a significant role in deciding the activity of drug against cell proliferation, whereas multiple gene knockout analysis gave better correlation results. We validated our theoretical results experimentally and showed that the drugs mitotane and myxothiazol can inhibit the growth of at least four cell-lines of NCI-60 database. |
format |
article |
author |
Abhijit Paul Rajat Anand Sonali Porey Karmakar Surender Rawat Nandadulal Bairagi Samrat Chatterjee |
author_facet |
Abhijit Paul Rajat Anand Sonali Porey Karmakar Surender Rawat Nandadulal Bairagi Samrat Chatterjee |
author_sort |
Abhijit Paul |
title |
Exploring gene knockout strategies to identify potential drug targets using genome-scale metabolic models |
title_short |
Exploring gene knockout strategies to identify potential drug targets using genome-scale metabolic models |
title_full |
Exploring gene knockout strategies to identify potential drug targets using genome-scale metabolic models |
title_fullStr |
Exploring gene knockout strategies to identify potential drug targets using genome-scale metabolic models |
title_full_unstemmed |
Exploring gene knockout strategies to identify potential drug targets using genome-scale metabolic models |
title_sort |
exploring gene knockout strategies to identify potential drug targets using genome-scale metabolic models |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/5cc3d92f081c43a59c89d39d060694cf |
work_keys_str_mv |
AT abhijitpaul exploringgeneknockoutstrategiestoidentifypotentialdrugtargetsusinggenomescalemetabolicmodels AT rajatanand exploringgeneknockoutstrategiestoidentifypotentialdrugtargetsusinggenomescalemetabolicmodels AT sonaliporeykarmakar exploringgeneknockoutstrategiestoidentifypotentialdrugtargetsusinggenomescalemetabolicmodels AT surenderrawat exploringgeneknockoutstrategiestoidentifypotentialdrugtargetsusinggenomescalemetabolicmodels AT nandadulalbairagi exploringgeneknockoutstrategiestoidentifypotentialdrugtargetsusinggenomescalemetabolicmodels AT samratchatterjee exploringgeneknockoutstrategiestoidentifypotentialdrugtargetsusinggenomescalemetabolicmodels |
_version_ |
1718387570726928384 |